These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37078281)

  • 21. Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.
    Cudkowicz M; Chase MK; Coffey CS; Ecklund DJ; Thornell BJ; Lungu C; Mahoney K; Gutmann L; Shefner JM; Staley KJ; Bosch M; Foster E; Long JD; Bayman EO; Torner J; Yankey J; Peters R; Huff T; Conwit RA; ; Shinnar S; Patch D; Darras BT; Ellis A; Packer RJ; Marder KS; Chiriboga CA; Henchcliffe C; Moran JA; Nikolov B; Factor SA; Seeley C; Greenberg SM; Amato AA; DeGregorio S; Simuni T; Ward T; Kissel JT; Kolb SJ; Bartlett A; Quinn JF; Keith K; Levine SR; Gilles N; Coyle PK; Lamb J; Wolfe GI; Crumlish A; Mejico L; Iqbal MM; Bowen JD; Tongco C; Nabors LB; Bashir K; Benge M; McDonald CM; Henricson EK; Oskarsson B; Dobkin BH; Canamar C; Glauser TA; Woo D; Molloy A; Clark P; Vollmer TL; Stein AJ; Barohn RJ; Dimachkie MM; Le Pichon JB; Benatar MG; Steele J; Wechsler L; Clemens PR; Amity C; Holloway RG; Annis C; Goldberg MP; Andersen M; Iannaccone ST; Smith AG; Singleton JR; Doudova M; Haley EC; Quigg MS; Lowenhaupt S; Malow BA; Adkins K; Clifford DB; Teshome MA; Connolly N
    JAMA Neurol; 2020 Jun; 77(6):755-763. PubMed ID: 32202612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National Institutes of Health StrokeNet During the Time of COVID-19 and Beyond.
    Broderick JP; Elm JJ; Janis LS; Zhao W; Moy CS; Dillon CR; Chimowitz MI; Sacco RL; Cramer SC; Wolf SL; Johnston KC; Saver JL; Marshall RS; Brown D; Wintermark M; Elkind MSV; Kamel H; Tirschwell DL; Longstreth WT; Chervin RD; Adeoye OM; Barreto AD; Grotta JC; Ramey SL; Lo WD; Feng W; Schlaug G; Sheth KN; Selim M; Naidech AM; Lansberg MG; Lazar RM; Albers GW; Griffin JS; Sirline LP; Frasure J; Wright CB; Khatri P;
    Stroke; 2020 Aug; 51(8):2580-2586. PubMed ID: 32716819
    [No Abstract]   [Full Text] [Related]  

  • 23. Choosing a covariate-adaptive randomization procedure in practice.
    Zagoraiou M
    J Biopharm Stat; 2017; 27(5):845-857. PubMed ID: 28166466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A matching algorithm to address imbalances in study populations: application to the National Institute of Neurological Diseases and Stroke Recombinant Tissue Plasminogen Activator acute stroke trial.
    Mandava P; Kalkonde YV; Rochat RH; Kent TA
    Stroke; 2010 Apr; 41(4):765-70. PubMed ID: 20167911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies.
    Külkens S; Hacke W
    Expert Rev Neurother; 2007 Jul; 7(7):783-8. PubMed ID: 17610385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of acute mechanical revascularization in large stroke (ASPECTS ⩽5) and large vessel occlusion within 7 h of last-seen-well: The LASTE multicenter, randomized, clinical trial protocol.
    Costalat V; Lapergue B; Albucher JF; Labreuche J; Henon H; Gory B; Sibon I; Boulouis G; Cognard C; Nouri N; Richard S; Marnat G; Di Maria F; Annan M; Duhamel A; Cagnazzo F; Jovin T; Arquizan C;
    Int J Stroke; 2024 Jan; 19(1):114-119. PubMed ID: 37462028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial: an adaptive trial design case study.
    Connor JT; Broglio KR; Durkalski V; Meurer WJ; Johnston KC
    Trials; 2015 Mar; 16():72. PubMed ID: 25885963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of dynamic block randomization and minimization in randomized trials: a simulation study.
    Xiao L; Lavori PW; Wilson SR; Ma J
    Clin Trials; 2011 Feb; 8(1):59-69. PubMed ID: 21335590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.
    Pancioli AM; Broderick J; Brott T; Tomsick T; Khoury J; Bean J; del Zoppo G; Kleindorfer D; Woo D; Khatri P; Castaldo J; Frey J; Gebel J; Kasner S; Kidwell C; Kwiatkowski T; Libman R; Mackenzie R; Scott P; Starkman S; Thurman RJ;
    Stroke; 2008 Dec; 39(12):3268-76. PubMed ID: 18772447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of selection bias assessment in the NINDS rt-PA stroke study.
    Garg R; Mickenautsch S
    BMC Med Res Methodol; 2022 Jun; 22(1):172. PubMed ID: 35705913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics and trends of clinical trials funded by the National Institutes of Health between 2005 and 2015.
    Gresham GK; Ehrhardt S; Meinert JL; Appel LJ; Meinert CL
    Clin Trials; 2018 Feb; 15(1):65-74. PubMed ID: 28879782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Reperfusion After Thrombolysis With Clinical Outcome Across the 4.5- to 9-Hours and Wake-up Stroke Time Window: A Meta-Analysis of the EXTEND and EPITHET Randomized Clinical Trials.
    Campbell BCV; Ma H; Parsons MW; Churilov L; Yassi N; Kleinig TJ; Hsu CY; Dewey HM; Butcher KS; Yan B; Desmond PM; Wijeratne T; Curtze S; Barber PA; De Silva DA; Thijs V; Levi CR; Bladin CF; Sharma G; Bivard A; Donnan GA; Davis SM
    JAMA Neurol; 2021 Feb; 78(2):236-240. PubMed ID: 33137171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial monitoring: hit or miss?
    Cohen J
    Science; 1994 Jun; 264(5165):1534-7. PubMed ID: 8202707
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of the National Institutes of Health on radiology research.
    Itagaki MW
    Radiology; 2008 Apr; 247(1):213-9. PubMed ID: 18372469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Executive summary of the National Institute of Neurological Disorders and Stroke conference on Emergency Neurologic Clinical Trials Network.
    Barsan WG; Pancioli AM; Conwit RA
    Ann Emerg Med; 2004 Oct; 44(4):407-12. PubMed ID: 15459625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal sufficient balance randomization for sequential randomized controlled trial designs: results from the ESCAPE trial.
    Sajobi TT; Singh G; Lowerison MW; Engbers J; Menon BK; Demchuk AM; Goyal M; Hill MD
    Trials; 2017 Nov; 18(1):516. PubMed ID: 29096678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S; Toni D;
    Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of balancing properties of stratified randomization procedures.
    Kundt G
    Methods Inf Med; 2009; 48(2):129-34. PubMed ID: 19283309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CREST-2: Identifying the Best Method of Stroke Prevention for Carotid Artery Stenosis: National Institute of Neurological Disorders and Stroke Organizational Update.
    Mott M; Koroshetz W; Wright CB
    Stroke; 2017 May; 48(5):e130-e131. PubMed ID: 28386040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.